Anixa Biosciences Ownership 2024 | Who Owns Anixa Biosciences Now?
Institutional Ownership
17.41%
Insider Ownership
5.05%
Retail Ownership
77.55%
Institutional Holders
51.00
Anixa Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.36% | 0.00% | 1,392,906 | - | - | 3,078,322 | Jun 30, 2024 |
| D.A. DAVIDSON & CO. | 2.31% | 0.01% | 736,415 | 736,415 | 100.00% | 1,627,477,000 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 1.89% | 0.19% | 604,235 | - | - | 1,335,359 | Jun 30, 2024 |
| UBS GROUP AG | 1.66% | 0.00% | 530,540 | -5,767 | -1.08% | 1,172,493 | Jun 30, 2024 |
| MISSION WEALTH MANAGEMENT, LP | 1.57% | 0.03% | 502,420 | - | - | 1,110,349 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.04% | 0.00% | 330,575 | 10,427 | 3.26% | 730,753 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.68% | - | 216,914 | 100,000 | 85.53% | 479,380 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.52% | 0.01% | 165,701 | - | - | 366,199 | Jun 30, 2024 |
| BLACKROCK INC. | 0.50% | - | 160,416 | 5,754 | 3.72% | 354,519 | Jun 30, 2024 |
| STATE STREET CORP | 0.35% | - | 111,900 | 3,400 | 3.13% | 247,299,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.23% | - | 73,050 | -14,000 | -16.08% | 161,442 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.22% | - | 71,040 | 8,378 | 13.37% | 156,998,000 | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | 0.15% | 0.01% | 46,894 | 2,600 | 5.87% | 103,636 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.13% | 0.00% | 41,000 | - | - | 91,000 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 0.12% | 0.00% | 37,400 | - | - | 82,654 | Jun 30, 2024 |
| GEMMER ASSET MANAGEMENT LLC | 0.11% | 0.01% | 35,000 | - | - | 77,350 | Jun 30, 2024 |
| MORGAN STANLEY | 0.11% | - | 34,501 | -2,635 | -7.10% | 76,248 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.10% | - | 31,292 | 4,600 | 17.23% | 69,155 | Jun 30, 2024 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 0.08% | 0.00% | 25,649 | 25,649 | 100.00% | 56,684 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.08% | 0.00% | 24,000 | 24,000 | 100.00% | 53,040 | Jun 30, 2024 |
Anixa Biosciences's largest institutional shareholder is VANGUARD GROUP INC, holding 4.36% of the company's total share outstanding, currently valued at $3.08M. The top 10 institutional shareholders own together 14.89% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LAIRD NORTON TRUST COMPANY, LLC | 1.89% | 0.19% | 604,235 | - | - | 1,335,359 | Jun 30, 2024 |
| MISSION WEALTH MANAGEMENT, LP | 1.57% | 0.03% | 502,420 | - | - | 1,110,349 | Jun 30, 2024 |
| TYLER-STONE WEALTH MANAGEMENT | 0.07% | 0.02% | 21,008 | - | - | 46,428 | Jun 30, 2024 |
| CONCORDE ASSET MANAGEMENT, LLC | 0.04% | 0.02% | 13,969 | 13,969 | 100.00% | 30,871 | Jun 30, 2024 |
| LIFEPRO ASSET MANAGEMENT | 0.03% | 0.02% | 10,760 | 10,760 | 100.00% | 23,780 | Jun 30, 2024 |
| D.A. DAVIDSON & CO. | 2.31% | 0.01% | 736,415 | 736,415 | 100.00% | 1,627,477,000 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.52% | 0.01% | 165,701 | - | - | 366,199 | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | 0.15% | 0.01% | 46,894 | 2,600 | 5.87% | 103,636 | Jun 30, 2024 |
| GEMMER ASSET MANAGEMENT LLC | 0.11% | 0.01% | 35,000 | - | - | 77,350 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.06% | 0.01% | 18,432 | -122 | -0.66% | 40,735 | Jun 30, 2024 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 0.04% | 0.01% | 13,900 | - | - | 30,719 | Jun 30, 2024 |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 0.07% | 0.00% | 22,500 | 7,500 | 50.00% | 49,725 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.04% | 0.00% | 14,000 | - | - | 30,940 | Jun 30, 2024 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 0.08% | 0.00% | 25,649 | 25,649 | 100.00% | 56,684 | Jun 30, 2024 |
| PARK CIRCLE CO | 0.00% | 0.00% | 500 | - | - | 1,105 | Jun 30, 2024 |
| STALEY CAPITAL ADVISERS INC | 0.03% | 0.00% | 10,000 | - | - | 22,100 | Jun 30, 2024 |
| DAKOTA WEALTH MANAGEMENT | 0.05% | 0.00% | 15,000 | - | - | 33,150 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | 0.04% | 0.00% | 13,969 | - | - | 30,871 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.08% | 0.00% | 24,000 | 24,000 | 100.00% | 53,040 | Jun 30, 2024 |
| ADVISORY SERVICES NETWORK, LLC | 0.04% | 0.00% | 11,174 | - | - | 24,695 | Jun 30, 2024 |
The largest Anixa Biosciences shareholder by % of total assets is LAIRD NORTON TRUST COMPANY, LLC. The company owns 604.24K shares of Anixa Biosciences (ANIX), representing 0.19% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| D.A. DAVIDSON & CO. | 2.31% | 0.01% | 736,415 | 736,415 | 100.00% | 1,627,477,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.68% | - | 216,914 | 100,000 | 85.53% | 479,380 | Jun 30, 2024 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 0.08% | 0.00% | 25,649 | 25,649 | 100.00% | 56,684 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.08% | 0.00% | 24,000 | 24,000 | 100.00% | 53,040 | Jun 30, 2024 |
| CONCORDE ASSET MANAGEMENT, LLC | 0.04% | 0.02% | 13,969 | 13,969 | 100.00% | 30,871 | Jun 30, 2024 |
| LIFEPRO ASSET MANAGEMENT | 0.03% | 0.02% | 10,760 | 10,760 | 100.00% | 23,780 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.04% | 0.00% | 330,575 | 10,427 | 3.26% | 730,753 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.22% | - | 71,040 | 8,378 | 13.37% | 156,998,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.03% | - | 8,500 | 7,752 | 1036.36% | 18,785 | Jun 30, 2024 |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 0.07% | 0.00% | 22,500 | 7,500 | 50.00% | 49,725 | Jun 30, 2024 |
| BLACKROCK INC. | 0.50% | - | 160,416 | 5,754 | 3.72% | 354,519 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.10% | - | 31,292 | 4,600 | 17.23% | 69,155 | Jun 30, 2024 |
| STATE STREET CORP | 0.35% | - | 111,900 | 3,400 | 3.13% | 247,299,000 | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | 0.15% | 0.01% | 46,894 | 2,600 | 5.87% | 103,636 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 6,379 | 844 | 15.25% | 14,098 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.04% | - | 14,023 | 500 | 3.70% | 31,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 1,428 | 428 | 42.80% | 3,000 | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 400 | - | - | 884 | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | 10 | - | - | 22 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.04% | - | 12,785 | - | - | 28,255 | Jun 30, 2024 |
As of Jun 30 2024, Anixa Biosciences's largest institutional buyer is D.A. DAVIDSON & CO.. The company purchased 736.41K stocks of ANIX, valued at $1.63B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 3 | -93,340 | -100.00% | 6 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -68,800 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -26,372 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -20,501 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -16,655 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -16,156 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -15,897 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.23% | - | 73,050 | -14,000 | -16.08% | 161,442 | Jun 30, 2024 |
| UBS GROUP AG | 1.66% | 0.00% | 530,540 | -5,767 | -1.08% | 1,172,493 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 4,226 | -4,825 | -53.31% | 9,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.06% | - | 17,544 | -3,633 | -17.16% | 38,772 | Jun 30, 2024 |
| MORGAN STANLEY | 0.11% | - | 34,501 | -2,635 | -7.10% | 76,248 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,194 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.01% | - | 3,039 | -200 | -6.17% | 6,716 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.06% | 0.01% | 18,432 | -122 | -0.66% | 40,735 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 1.89% | 0.19% | 604,235 | - | - | 1,335,359 | Jun 30, 2024 |
| MISSION WEALTH MANAGEMENT, LP | 1.57% | 0.03% | 502,420 | - | - | 1,110,349 | Jun 30, 2024 |
| TYLER-STONE WEALTH MANAGEMENT | 0.07% | 0.02% | 21,008 | - | - | 46,428 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 0.52% | 0.01% | 165,701 | - | - | 366,199 | Jun 30, 2024 |
As of Jun 30 2024, Anixa Biosciences's biggest institutional seller is QUBE RESEARCH & TECHNOLOGIES LTD. The company sold -93.34K shares of ANIX, valued at $6.00.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| D.A. DAVIDSON & CO. | 2.31% | 0.01% | 736,415 | 736,415 | 100.00% | 1,627,477,000 | Jun 30, 2024 |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 0.08% | 0.00% | 25,649 | 25,649 | 100.00% | 56,684 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.08% | 0.00% | 24,000 | 24,000 | 100.00% | 53,040 | Jun 30, 2024 |
| LIFEPRO ASSET MANAGEMENT | 0.03% | 0.02% | 10,760 | 10,760 | 100.00% | 23,780 | Jun 30, 2024 |
Anixa Biosciences's largest new institutional shareholder by number of shares is D.A. DAVIDSON & CO., purchased 736.41K shares, valued at $1.63B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -68,800 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -26,372 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -20,501 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -16,655 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -16,156 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -15,897 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,194 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
Anixa Biosciences's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -68.80K shares, valued at -, as of undefined.
Anixa Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 12,599 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 21,000 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,348,499 | -420,658 | -23.78% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 8,093 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 289,688 | 13,980 | 5.07% | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 7,644 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,079 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 12,785 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 3,525 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,306 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 14,225 | - | - | Jan 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 3,590 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 4,426 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,059 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 65,957 | 289 | 0.44% | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 38 | - | - | Mar 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 386 | - | - | Mar 31, 2024 |
Anixa Biosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 12.60K shares, compromising 0.02% of its total assets.
Anixa Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 51 | -15.00% |
| 31 Mar, 24 | 60 | 3.45% |
| 31 Dec, 23 | 58 | 11.54% |
| 30 Sep, 23 | 52 | 10.64% |
| 30 Jun, 23 | 47 | 2.17% |
| 31 Mar, 23 | 46 | -11.54% |
| 31 Dec, 22 | 52 | 23.81% |
| 30 Sep, 22 | 42 | -10.64% |
| 30 Jun, 22 | 47 | 14.63% |
| 31 Mar, 22 | 41 | -8.89% |
| 31 Dec, 21 | 45 | 15.38% |
| 30 Sep, 21 | 39 | 18.18% |
| 30 Jun, 21 | 33 | 22.22% |
| 31 Mar, 21 | 27 | 35.00% |
| 31 Dec, 20 | 20 | - |
| 30 Sep, 20 | 20 | 11.11% |
| 30 Jun, 20 | 18 | 20.00% |
| 31 Mar, 20 | 15 | - |
| 31 Dec, 19 | 15 | - |
| 30 Sep, 19 | 15 | 7.14% |
| 30 Jun, 19 | 14 | - |
| 31 Mar, 19 | 14 | 7.69% |
| 31 Dec, 18 | 13 | - |
As of 30 Jun 24, 51 institutions are holding Anixa Biosciences's shares, representing a decrease of -15.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 5,555,557 | 5.34% |
| 31 Mar, 24 | 5,273,751 | 19.56% |
| 31 Dec, 23 | 4,410,795 | 12.28% |
| 30 Sep, 23 | 3,928,368 | 8.02% |
| 30 Jun, 23 | 3,636,857 | -0.76% |
| 31 Mar, 23 | 3,664,656 | 0.78% |
| 31 Dec, 22 | 3,636,202 | 4.65% |
| 30 Sep, 22 | 3,474,766 | 6.31% |
| 30 Jun, 22 | 3,268,470 | -1.09% |
| 31 Mar, 22 | 3,304,604 | -3.88% |
| 31 Dec, 21 | 3,437,987 | 8.20% |
| 30 Sep, 21 | 3,177,506 | 7.65% |
| 30 Jun, 21 | 2,951,798 | 17.50% |
| 31 Mar, 21 | 2,512,226 | 39.53% |
| 31 Dec, 20 | 1,800,474 | -1.45% |
| 30 Sep, 20 | 1,826,961 | 14.37% |
| 30 Jun, 20 | 1,597,366 | 15.47% |
| 31 Mar, 20 | 1,383,319 | 3.86% |
| 31 Dec, 19 | 1,331,888 | 1.45% |
| 30 Sep, 19 | 1,312,871 | 7.03% |
| 30 Jun, 19 | 1,226,634 | -1.98% |
| 31 Mar, 19 | 1,251,436 | 14.19% |
| 31 Dec, 18 | 1,095,942 | - |
Anixa Biosciences (ANIX) has 5.56M shares outstanding as of 30 Jun 24, up 5.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 17.41% | 6.19% |
| 31 Mar, 24 | 16.77% | 8.27% |
| 31 Dec, 23 | 14.24% | 8.85% |
| 30 Sep, 23 | 12.68% | 9.17% |
| 30 Jun, 23 | 11.76% | 8.37% |
| 31 Mar, 23 | 11.85% | 8.57% |
| 31 Dec, 22 | 11.76% | 8.99% |
| 30 Sep, 22 | 11.44% | 9.93% |
| 30 Jun, 22 | 10.73% | 8.94% |
| 31 Mar, 22 | 10.96% | 8.41% |
| 31 Dec, 21 | 11.41% | 9.23% |
| 30 Sep, 21 | 11.12% | 11.84% |
| 30 Jun, 21 | 9.69% | 12.62% |
| 31 Mar, 21 | 8.76% | 17.12% |
| 31 Dec, 20 | 7.15% | 13.57% |
| 30 Sep, 20 | 7.26% | 15.27% |
| 30 Jun, 20 | 6.90% | 16.13% |
| 31 Mar, 20 | 6.54% | 15.80% |
| 31 Dec, 19 | 6.43% | 16.00% |
| 30 Sep, 19 | 6.34% | 17.03% |
| 30 Jun, 19 | 6.10% | 15.04% |
| 31 Mar, 19 | 6.37% | 19.49% |
| 31 Dec, 18 | 5.72% | - |
As of 30 Jun 24, Anixa Biosciences is held by 17.41% institutional shareholders, representing a 6.19% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -40.00% |
| 31 Mar, 24 | 30 | 50.00% |
| 31 Dec, 23 | 20 | 42.86% |
| 30 Sep, 23 | 14 | -6.67% |
| 30 Jun, 23 | 15 | 25.00% |
| 31 Mar, 23 | 12 | -42.86% |
| 31 Dec, 22 | 21 | 50.00% |
| 30 Sep, 22 | 14 | -17.65% |
| 30 Jun, 22 | 17 | -10.53% |
| 31 Mar, 22 | 19 | - |
| 31 Dec, 21 | 19 | 18.75% |
| 30 Sep, 21 | 16 | -5.88% |
| 30 Jun, 21 | 17 | -10.53% |
| 31 Mar, 21 | 19 | 46.15% |
| 31 Dec, 20 | 13 | 30.00% |
| 30 Sep, 20 | 10 | -9.09% |
| 30 Jun, 20 | 11 | 83.33% |
| 31 Mar, 20 | 6 | -14.29% |
| 31 Dec, 19 | 7 | -12.50% |
| 30 Sep, 19 | 8 | 14.29% |
| 30 Jun, 19 | 7 | -12.50% |
| 31 Mar, 19 | 8 | -38.46% |
| 31 Dec, 18 | 13 | - |
18 institutional shareholders have increased their position in ANIX stock as of 30 Jun 24 compared to 30 in the previous quarter (a -40.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | 14.29% |
| 31 Mar, 24 | 7 | -46.15% |
| 31 Dec, 23 | 13 | -7.14% |
| 30 Sep, 23 | 14 | 75.00% |
| 30 Jun, 23 | 8 | -11.11% |
| 31 Mar, 23 | 9 | -25.00% |
| 31 Dec, 22 | 12 | 50.00% |
| 30 Sep, 22 | 8 | -33.33% |
| 30 Jun, 22 | 12 | 20.00% |
| 31 Mar, 22 | 10 | - |
| 31 Dec, 21 | 10 | - |
| 30 Sep, 21 | 10 | 100.00% |
| 30 Jun, 21 | 5 | -16.67% |
| 31 Mar, 21 | 6 | 20.00% |
| 31 Dec, 20 | 5 | - |
| 30 Sep, 20 | 5 | 25.00% |
| 30 Jun, 20 | 4 | - |
| 31 Mar, 20 | 4 | -20.00% |
| 31 Dec, 19 | 5 | 150.00% |
| 30 Sep, 19 | 2 | -33.33% |
| 30 Jun, 19 | 3 | -25.00% |
| 31 Mar, 19 | 4 | - |
| 31 Dec, 18 | - | - |
8 institutional shareholders have reduced their position in ANIX stock as of 30 Jun 24 compared to 7 in the previous quarter (a 14.29% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 51 | -15.00% | 5,555,557 | 5.34% | 17.41% | 6.19% | 18 | -40.00% | 8 | 14.29% |
| 31 Mar, 24 | 60 | 3.45% | 5,273,751 | 19.56% | 16.77% | 8.27% | 30 | 50.00% | 7 | -46.15% |
| 31 Dec, 23 | 58 | 11.54% | 4,410,795 | 12.28% | 14.24% | 8.85% | 20 | 42.86% | 13 | -7.14% |
| 30 Sep, 23 | 52 | 10.64% | 3,928,368 | 8.02% | 12.68% | 9.17% | 14 | -6.67% | 14 | 75.00% |
| 30 Jun, 23 | 47 | 2.17% | 3,636,857 | -0.76% | 11.76% | 8.37% | 15 | 25.00% | 8 | -11.11% |
| 31 Mar, 23 | 46 | -11.54% | 3,664,656 | 0.78% | 11.85% | 8.57% | 12 | -42.86% | 9 | -25.00% |
| 31 Dec, 22 | 52 | 23.81% | 3,636,202 | 4.65% | 11.76% | 8.99% | 21 | 50.00% | 12 | 50.00% |
| 30 Sep, 22 | 42 | -10.64% | 3,474,766 | 6.31% | 11.44% | 9.93% | 14 | -17.65% | 8 | -33.33% |
| 30 Jun, 22 | 47 | 14.63% | 3,268,470 | -1.09% | 10.73% | 8.94% | 17 | -10.53% | 12 | 20.00% |
| 31 Mar, 22 | 41 | -8.89% | 3,304,604 | -3.88% | 10.96% | 8.41% | 19 | - | 10 | - |
| 31 Dec, 21 | 45 | 15.38% | 3,437,987 | 8.20% | 11.41% | 9.23% | 19 | 18.75% | 10 | - |
| 30 Sep, 21 | 39 | 18.18% | 3,177,506 | 7.65% | 11.12% | 11.84% | 16 | -5.88% | 10 | 100.00% |
| 30 Jun, 21 | 33 | 22.22% | 2,951,798 | 17.50% | 9.69% | 12.62% | 17 | -10.53% | 5 | -16.67% |
| 31 Mar, 21 | 27 | 35.00% | 2,512,226 | 39.53% | 8.76% | 17.12% | 19 | 46.15% | 6 | 20.00% |
| 31 Dec, 20 | 20 | - | 1,800,474 | -1.45% | 7.15% | 13.57% | 13 | 30.00% | 5 | - |
| 30 Sep, 20 | 20 | 11.11% | 1,826,961 | 14.37% | 7.26% | 15.27% | 10 | -9.09% | 5 | 25.00% |
| 30 Jun, 20 | 18 | 20.00% | 1,597,366 | 15.47% | 6.90% | 16.13% | 11 | 83.33% | 4 | - |
| 31 Mar, 20 | 15 | - | 1,383,319 | 3.86% | 6.54% | 15.80% | 6 | -14.29% | 4 | -20.00% |
| 31 Dec, 19 | 15 | - | 1,331,888 | 1.45% | 6.43% | 16.00% | 7 | -12.50% | 5 | 150.00% |
| 30 Sep, 19 | 15 | 7.14% | 1,312,871 | 7.03% | 6.34% | 17.03% | 8 | 14.29% | 2 | -33.33% |
| 30 Jun, 19 | 14 | - | 1,226,634 | -1.98% | 6.10% | 15.04% | 7 | -12.50% | 3 | -25.00% |
| 31 Mar, 19 | 14 | 7.69% | 1,251,436 | 14.19% | 6.37% | 19.49% | 8 | -38.46% | 4 | - |
| 31 Dec, 18 | 13 | - | 1,095,942 | - | 5.72% | - | 13 | - | - | - |
Anixa Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of ANIX was made by Titterton Lewis H jr on Aug 01 2024, buying 5,580 shares at $3.23 per share (worth $18.02K).
Anixa Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | - | - |
| Q2 2024 | 9 | - | - |
| Q1 2024 | 7 | - | - |
| Q4 2023 | 2 | 1 | 200.00% |
| Q3 2023 | 3 | 5 | 60.00% |
| Q2 2023 | 1 | - | - |
| Q1 2023 | 10 | - | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 2 | 4 | 50.00% |
| Q2 2022 | 8 | 1 | 800.00% |
| Q1 2022 | 15 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | 9 | - | - |
| Q2 2021 | 11 | 1 | 1100.00% |
| Q1 2021 | 5 | 1 | 500.00% |
| Q4 2020 | 3 | - | - |
| Q3 2020 | 7 | - | - |
| Q2 2020 | 4 | - | - |
| Q1 2020 | 8 | - | - |
| Q4 2019 | 8 | 1 | 800.00% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Anixa Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | - | - |
| Q2 2024 | 8 | - | - |
| Q1 2024 | 2 | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 9 | - | - |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | 3 | - | - |
| Q1 2020 | 8 | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 5 open market buy trades and 0 open market sell trades of Anixa Biosciences's stocks.
Anixa Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| CUE | Cue Biopharma, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| ANTX | AN2 Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| INAB | IN8bio, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| ANVS | Annovis Bio, Inc. |
| INMB | INmune Bio, Inc. |
| PYPD | PolyPid Ltd. |
| IMNM | Immunome, Inc. |
ANIX Ownership FAQ
Who Owns Anixa Biosciences?
Anixa Biosciences is owned by institutional shareholders (17.41%), insiders (5.05%), and public (77.55%). The largest institutional shareholder of Anixa Biosciences is VANGUARD GROUP INC (4.36% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.02% of total shares).
Who are the major institutional shareholders of Anixa Biosciences?
Anixa Biosciences's major institutional shareholders are VANGUARD GROUP INC, D.A. DAVIDSON & CO., LAIRD NORTON TRUST COMPANY, LLC, UBS GROUP AG, and MISSION WEALTH MANAGEMENT, LP. The top five shareholders own together 11.80% of the company's share outstanding.
How many Anixa Biosciences shareholders are there?
As of Jun 2024, there are 51 institutional shareholders of Anixa Biosciences.
What percentage of Anixa Biosciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 1.39M shares of Anixa Biosciences, representing 4.36% of the company's total shares outstanding, valued at $3.08M (as of Jun 2024).
What percentage of Anixa Biosciences is owned by D.A. DAVIDSON & CO?
As of Jun 2024, D.A. DAVIDSON & CO holds 736.42K shares of Anixa Biosciences (ANIX), compromising 2.31% of the company, valued at $1.63B.
What percentage of Anixa Biosciences is owned by LAIRD NORTON TRUST COMPANY, LLC?
LAIRD NORTON TRUST COMPANY, LLC is the third largest holder of Anixa Biosciences. The company owns 604.24K of the company's shares outstanding (worth $1.34M).